Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.
about
Emerging roles for intersectin (ITSN) in regulating signaling and disease pathwaysArtificial intelligence in hematology.Differentially expressed genes in adult familial myelodysplastic syndromes.Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemiaInterferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.Breast cancer stem cells: Multiple capacities in tumor metastasis.Interleukin-3 receptor in acute leukemia.Requirement for ssbp2 in hematopoietic stem cell maintenance and stress responsePhosphorylation of the SSBP2 and ABL proteins by the ZNF198-FGFR1 fusion kinase seen in atypical myeloproliferative disorders as revealed by phosphopeptide-specific MS.SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemiaMyc roles in hematopoiesis and leukemiaGenetic pathways leading to therapy-related myeloid neoplasms.Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.FHL2 regulates hematopoietic stem cell functions under stress conditionsPhosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesisAltered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.Breast cancer stem cells, cytokine networks, and the tumor microenvironment.Similarities and differences between therapy-related and elderly acute myeloid leukemia.Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles.Gene expression profiling and its application in studies of haematological malignancy.Single-stranded DNA-binding proteins regulate the abundance of LIM domain and LIM domain-binding proteins.Reproducibility, fidelity, and discriminant validity of mRNA amplification for microarray analysis from primary hematopoietic cells.Intersectin 1 is required for neuroblastoma tumorigenesis.Dendritic cells in MDS and AML--cause, effect or solution to the immune pathogenesis of disease?Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia.Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.Therapy-related myeloid leukemia.Influence of DNA damage and repair upon the risk of treatment related leukemia.Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.Therapy-related myeloid neoplasms.The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiationCharacterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response.Pharmacogenomics in acute myeloid leukemia.Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.
P2860
Q26824407-30A7C13F-4CEE-4945-9E04-2A79E9785F0FQ30351531-8F4302BA-D066-476F-9E07-F98C70B76DDCQ33197003-F932A676-5771-413B-8CA7-FBB6968CFBAFQ34076003-D8EA9E23-ADD1-4448-BDE7-FF04DF9E102EQ34177965-DEF7D98F-3F86-44F0-A752-81C36DA811F2Q34257303-059D12D7-7D8B-4121-8EB3-19EA26422C88Q34283145-D765DA1F-1F4C-4BED-A2A9-615C9450BCA0Q34364759-DA953491-EDBC-476C-B364-C260B467DDD8Q34378275-FAFB6AE0-CD58-45EF-BD3B-3DB5F055EF3CQ34405256-324FF9F2-50FF-4463-B24A-45EC77B3145BQ34962889-4FC529FF-3965-45F8-AF7D-B9DCE5DC9398Q34972364-95E3AAC5-D14A-4772-BF02-61D71BB03A78Q35039992-4147A7CC-4306-45F2-B29C-384A2BCB3D93Q35040064-0751BC39-50B8-4A0D-B878-8C80E15BC52EQ35137904-DA1D7351-390F-4697-8FDF-41A64B7F27C3Q35153937-25D685EB-A16D-4ADB-9E0B-7D6B176D71B6Q35563771-759DFEB4-6B48-4D93-9FBF-42404A9E5933Q35571904-5816AB92-1384-4C08-A3D7-7B616A2FD2CAQ35640731-955868AC-96E6-48BF-BFBC-8922D1727541Q35653085-04CA540A-DE75-4EA1-9617-7B6603C2577EQ35661018-18BD3A7B-CB42-4301-82F8-2812DDDB7EBDQ35741894-A6C7C5A4-0C00-41AF-BB0A-C798DC442AA0Q35789833-E3AE8FF7-0329-4C19-A1E3-57F1AE366A12Q35916258-64CB5040-77D0-45DD-A017-9FAA7920D9CCQ36021493-E561B9AA-EF1C-4E51-ADE3-7F08CC4F09FCQ36125618-DFF7419D-F561-4DD7-B7A5-844F3AB6A866Q36129030-26D883C6-7BAA-48F8-B789-AB033460E6B4Q36194631-569B1C7C-7E32-4928-A88C-633C900BA9B4Q36274109-C275BA09-F9B6-4046-BCCF-39CFBFA6C4F1Q36402208-0B3FC2B6-DC00-40C9-90FF-5180DC5DA2A0Q36600942-EC632958-51C0-46D4-A210-A8334A22FA7AQ36988558-4890391A-E5CA-40E5-898D-375614EB54D2Q37009760-89F1B5BD-9E9C-4B84-8D1D-9AF58EAAB271Q37071688-C5530B0D-BCAE-445D-8122-52BF3CFE4766Q37109753-389537CE-5FE7-48C8-903F-1B30EFFA7EE2Q37428433-9C12203C-5D7E-4AB6-AA79-8E8135468AF2Q37446105-BE489ADC-9794-4F90-BBA6-2731F326BC8EQ37612440-F9444C59-C75A-4499-89BB-8387A0E39693Q37627876-3A69C09D-EAE0-4C2C-A868-A67FB7B54F07Q37683754-32FF4A50-73B3-4374-83BA-1FB55D44EAA3
P2860
Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@ast
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@en
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@nl
type
label
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@ast
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@en
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@nl
prefLabel
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@ast
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@en
Expression profiling of CD34+ ...... elated acute myeloid leukemia.
@nl
P2093
P2860
P356
P1476
Expression profiling of CD34+ ...... related acute myeloid leukemia
@en
P2093
Anthony A Fernald
Lucy A Godley
Michelle M Le Beau
Zhijian Qian
P2860
P304
14925-14930
P356
10.1073/PNAS.222491799
P407
P577
2002-11-04T00:00:00Z